L’Oreal (EPA:OREP) shares climbed 0.7% in Paris on Tuesday following an upgrade from Exane BNP Paribas, which moved the stock to neutral from underperform.
The brokerage justified the change in stance by highlighting the company’s capacity to manage through inflationary spikes. As Exane BNP Paribas put it, "L’Oreal has historically dealt with inflation pressures with aplomb," a quality the broker said supports a less cautious view of the stock.
Exane BNP Paribas also argued that L’Oreal faces relatively smaller exposure to the structural headwinds that have contributed to slowing growth across the cosmetics sector. That assessment underpinned the decision to lift the firm’s recommendations.
Alongside the rating change, the broker increased its price target by 18%, taking it from 350 euros to 414 euros - a figure the report equated to $483.6 when converted to U.S. dollars. The analyst note added that "L’Oreal’s elevated sector relative valuation feels a rather moot point at present," signaling that the broker sees the company’s near-term fundamentals as outweighing relative valuation concerns.
The share move in Paris reflects the market response to the broker’s reassessment rather than any new corporate disclosure or operational update from L’Oreal itself. The upgrade and the higher price target are the explicit drivers cited for the intraday move.
Context and implications
Exane BNP Paribas’ upgrade emphasizes inflation resilience as the central factor in its revised view. The brokerage’s commentary frames L’Oreal as better positioned than some peers to navigate inflationary episodes, while also signaling that sector-wide structural pressures are a lesser concern for the company according to the note.
The price-target increase and the neutral rating change together offer investors a clearer lens on the broker’s expectations, even as the note explicitly downplays the relevance of relative valuation within the sector at this time.